Logo
MINIMAL RESIDUAL DISEASE TESTING MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
  2. / Industry Reports
  3. Minimal Residual Disease Testing Market Analysis
all report title image

MINIMAL RESIDUAL DISEASE TESTING MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Minimal Residual Disease Testing Market, By Technology (Flow Cytometry, Polymerase chain reaction (PCR), and Next generation sequencing), By Application (Lymphoma, Solid Tumors, and Others), By End User (Hospitals, Clinics, Research Laboratories, and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

  • Published In : Apr 2024
  • Code : CMI6888
  • Pages :173
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

Market Concentration and Competitive Landscape

Minimal Residual Disease Testing Market Concentration By Players

Close-monitor your Competitor's Move, Get Instant Access to the Report

Key Players Insights
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd
  • Guardant Health, Inc.
  • Adaptive Biotechnologies
  • Invitae Corporation
  • ASURAGEN, INC.
  • Invivoscribe, Inc. 
  • Laboratory Corporation of America Holdings
  • Natera, Inc.
  • Sysmex Inostics, Inc.
  • Amgen Inc.
  • FOUNDATION MEDICINE, INC.
  • Sebia
  • Myriad Genetics, Inc.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.